DK3263116T3 - Guldpartikel til anvendelse i terapi til forebyggelse af ardannelse - Google Patents
Guldpartikel til anvendelse i terapi til forebyggelse af ardannelse Download PDFInfo
- Publication number
- DK3263116T3 DK3263116T3 DK17178814.4T DK17178814T DK3263116T3 DK 3263116 T3 DK3263116 T3 DK 3263116T3 DK 17178814 T DK17178814 T DK 17178814T DK 3263116 T3 DK3263116 T3 DK 3263116T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapy
- formation
- gold particle
- prevent harm
- harm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16176880 | 2016-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3263116T3 true DK3263116T3 (da) | 2022-11-14 |
Family
ID=56345004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17178814.4T DK3263116T3 (da) | 2016-06-29 | 2017-06-29 | Guldpartikel til anvendelse i terapi til forebyggelse af ardannelse |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20180000861A1 (da) |
| EP (2) | EP4144355A1 (da) |
| DK (1) | DK3263116T3 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4406543A1 (en) * | 2023-01-24 | 2024-07-31 | AuroDerm ApS | Gold particle for use in therapy to prevent or reduce the formation of biofilm in patients who are to receive, are receiving, or have received soft tissue filler |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2447614C (en) * | 2001-05-25 | 2009-08-11 | Gorm Danscher | A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| DK200801559A (en) * | 2008-11-11 | 2010-05-12 | Berlock Holding Aps | Gold devices for suppressing local inflammation |
| US10111904B2 (en) * | 2013-01-09 | 2018-10-30 | Berlock Aps | Micron-sized gold, kit comprising said gold and its use as a non-toxic immune suppressor |
-
2017
- 2017-06-29 DK DK17178814.4T patent/DK3263116T3/da active
- 2017-06-29 EP EP22189330.8A patent/EP4144355A1/en not_active Withdrawn
- 2017-06-29 EP EP17178814.4A patent/EP3263116B1/en active Active
- 2017-06-29 US US15/637,959 patent/US20180000861A1/en not_active Abandoned
-
2020
- 2020-08-14 US US16/993,765 patent/US20210093662A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3263116A1 (en) | 2018-01-03 |
| EP4144355A1 (en) | 2023-03-08 |
| US20180000861A1 (en) | 2018-01-04 |
| US20210093662A1 (en) | 2021-04-01 |
| EP3263116B1 (en) | 2022-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282202A (en) | Compositions and methods for personalized neoplasia vaccines | |
| DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
| PL3542798T3 (pl) | Aceklidyna do zastosowania w leczeniu starczowzroczności | |
| DK3046583T3 (da) | Viruslignende partikelkonjugater til behandling af tumorer | |
| DK3033086T3 (da) | Kombinationsterapi til behandling af cancer | |
| DK3331915T3 (da) | Immun-checkpoint-inhibitorer til anvendelse til behandling af blodbårne cancere | |
| IL243324A0 (en) | Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors | |
| DK3060237T3 (da) | Modificeret omprogrammeringsprotein til anvendelse i behandling af cancer | |
| IL251890A0 (en) | Combination immunotherapy approach for treatment of cancer | |
| DK3033102T3 (da) | Peptidkonjugerede partikler | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| HUE050095T2 (hu) | Anyagcsere-rendellenességek kezelése lófélékben | |
| DK2994533T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
| DK3007695T3 (da) | Sammensætninger og fremgangsmåder til behandling af anæmi | |
| DK3082829T3 (da) | Sglt2-inhibitorer til behandlingen af metaboliske lidelser i kattedyr | |
| PL3186244T3 (pl) | Analogi dioksolanowe urydyny w leczeniu raka | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3236960T3 (da) | Fluralaner til anvendelse i behandling af demodicose | |
| DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
| DK2976072T3 (da) | Epinephrinfinpartikler og fremgangsmåder til anvendelse deraf til behandling af tilstande, der reagerer på epinephrin | |
| HUE047062T2 (hu) | Angiotenzin II alacsony vérnyomás kombinációs kezelésére | |
| DK3363428T3 (da) | Perfusionsdoseringsform | |
| DK3511004T3 (da) | Kombineret præparat til behandling af cancer | |
| SI2991633T1 (sl) | Terapija za bakteriofagi |